These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 6818929)

  • 41. [Biological properties, serogroup affiliation and antibiotic sensitivity of hospital strains of Pseudomonas aeruginosa].
    Minukhin VV; Tsyganenko AIa; Kravtsova VI
    Mikrobiol Zh (1978); 1986; 48(5):10-5. PubMed ID: 3152122
    [No Abstract]   [Full Text] [Related]  

  • 42. Type III protein secretion is associated with death in lower respiratory and systemic Pseudomonas aeruginosa infections.
    Roy-Burman A; Savel RH; Racine S; Swanson BL; Revadigar NS; Fujimoto J; Sawa T; Frank DW; Wiener-Kronish JP
    J Infect Dis; 2001 Jun; 183(12):1767-74. PubMed ID: 11372029
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Roles of exoenzymes and exotoxin in the pathogenicity of Pseudomonas aeruginosa and the development of a new vaccine.
    Homma JY
    Jpn J Exp Med; 1980 Jun; 50(3):149-65. PubMed ID: 6776324
    [No Abstract]   [Full Text] [Related]  

  • 44. Clinical response to azithromycin in cystic fibrosis correlates with in vitro effects on Pseudomonas aeruginosa phenotypes.
    Nguyen D; Emond MJ; Mayer-Hamblett N; Saiman L; Marshall BC; Burns JL
    Pediatr Pulmonol; 2007 Jun; 42(6):533-41. PubMed ID: 17469154
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Virulence factors of Pseudomonas aeruginosa].
    Vaca Pacheco S; Cervantes-Vega C
    Rev Latinoam Microbiol; 1988; 30(2):87-90. PubMed ID: 3146123
    [No Abstract]   [Full Text] [Related]  

  • 46. [Immunoprophylaxis and immunotherapy of infection caused by Pseudomonas aeruginosa: research results and prospects].
    Stanislavskiĭ ES; Joó I
    Zh Mikrobiol Epidemiol Immunobiol; 1983 Jul; (7):22-31. PubMed ID: 6414198
    [No Abstract]   [Full Text] [Related]  

  • 47. [O-serovars and antibiotic sensitivities in strains of Pseudomonas aeruginosa of human and animal origin].
    Zschöck M; Schliesser T
    Zentralbl Veterinarmed B; 1986 Aug; 33(6):440-6. PubMed ID: 3098000
    [No Abstract]   [Full Text] [Related]  

  • 48. [Strategy of antibiotic therapy in the course of chronic Pseudomonas aeruginosa infection].
    Bassinet L
    Rev Mal Respir; 2003 Apr; 20(2 Pt 2):S118-28. PubMed ID: 12910144
    [No Abstract]   [Full Text] [Related]  

  • 49. [The relationship between different serological types of Pseudomonas aeruginosa strain in lower respiratory tract and its clinical significance].
    He G; Li H; Xu H
    Zhonghua Jie He He Hu Xi Za Zhi; 1998 Oct; 21(10):584-7. PubMed ID: 11477871
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Effects of azithromycin on the virulence of Pseudomonas aeruginosa].
    Reinert P
    Pathol Biol (Paris); 1995 Jun; 43(6):551-3. PubMed ID: 8539081
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Regulation of virulence and antibiotic resistance by two-component regulatory systems in Pseudomonas aeruginosa.
    Gooderham WJ; Hancock RE
    FEMS Microbiol Rev; 2009 Mar; 33(2):279-94. PubMed ID: 19243444
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Prophylactic effects of Pseudomonas aeruginosa vaccine on patients with chronic pulmonary disease].
    Tateda K; Yamaguchi K
    Nihon Rinsho; 1991 Oct; 49(10):2416-20. PubMed ID: 1749098
    [No Abstract]   [Full Text] [Related]  

  • 53. [Observations on the clinical and bacteriological aspects of the respiratory localization of Pseudomonas aeruginosa].
    Velluti G; Grifa P; Marchioni CF
    G Mal Infett Parassit; 1968 Aug; 20(8):719-29. PubMed ID: 4976934
    [No Abstract]   [Full Text] [Related]  

  • 54. [Postoperative infections due to Pseudomonas aeruginosa].
    Ishikawa S; Yura J
    Nihon Rinsho; 1991 Oct; 49(10):2336-41. PubMed ID: 1721097
    [No Abstract]   [Full Text] [Related]  

  • 55. [Susceptibility patterns of Pseudomonas aeruginosa strains isolated in the Monastir region, Tunisia].
    Abdallah HB; Noomen S; Khélifa AB; Sahnoun O; Elargoubi A; Mastouri M
    Med Mal Infect; 2008 Oct; 38(10):554-6. PubMed ID: 18814981
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antibiotic susceptibility and serotyping of Pseudomonas aeruginosa strains isolated from surface waters, thermomineral waters and clinical specimens.
    Reali D; Rosati S
    Zentralbl Hyg Umweltmed; 1994 Aug; 196(1):75-80. PubMed ID: 7802899
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Experimental chronic Pseudomonas aeruginosa lung infection in rats. Non-specific stimulation with LPS reduces lethality as efficiently as specific immunization.
    Lange KH; Hougen HP; Høiby N; Fomsgaard A; Rygaard J; Johansen HK
    APMIS; 1995 May; 103(5):367-74. PubMed ID: 7654361
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Quantitative variations in beta-lactam antibiotic released endotoxin from Pseudomonas aeruginosa: in-vivo relevance.
    Jackson JJ; Kropp H
    Prog Clin Biol Res; 1995; 392():235-51. PubMed ID: 8524928
    [No Abstract]   [Full Text] [Related]  

  • 59. [Clinical use of a Soviet polyvalent corpuscular pyocyanic vaccine for the prevention of Pseudomonas aeruginosa infection in thermal burn victims].
    Gerasimova LI; Moroz AF; Radkevich SA; Sveshnikov AI; Mizikin EV
    Khirurgiia (Mosk); 1980 Nov; (11):36-41. PubMed ID: 6777578
    [No Abstract]   [Full Text] [Related]  

  • 60. Clinical, microbiologic, and epidemiologic characteristics of Pseudomonas aeruginosa infections in a University Hospital, Malatya, Turkey.
    Yetkin G; Otlu B; Cicek A; Kuzucu C; Durmaz R
    Am J Infect Control; 2006 May; 34(4):188-92. PubMed ID: 16679175
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.